Effect of Metformin Use on Mortality in Diabetic and Non Diabetic Patients With Sepsis and Septic Shock.
Status:
Not yet recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
We aimed to determine if metformin use in both diabetic and non diabetic patients with sepsis
and septic shock affects 28 day mortality and its effect on inflammatory markers. Plasma
rennin, serum lactate concentration and IL6 will be measured for predicting 28 days
in-hospital mortality in patients with sepsis.